Gorbunov M A, Pavlova L I, Rozhkov S D, Kukharev A I, Novikov V Iu, Karpovich L G, Kalashnikova T V, Bektimirov T A, Zelenov I A, Levina V D, Belashev B P, Ermolaeva T N, Doroshenko N V, Maĭdaniuk A T
Tarasevich State Research Institute for Standartization and Control of Medical Biological Preparations, Moscow, Russia.
Zh Mikrobiol Epidemiol Immunobiol. 1998 Jan-Feb(1):50-4.
The results of the study of the reactogenicity, safety and immunological activity of Russian cultural vaccine against hepatitis A are presented. The vaccine was found to have specific safety, moderate reactogenicity and pronounced immunological activity. In addition, the study of the prophylactic efficiency of the vaccine in the pre-epidemic period of the outbreak of hepatitis A morbidity in a group exceeding 14,000 adults was carried out. The study revealed high prophylactic efficiency of the vaccine (its efficiency rate was equal to 97.7%). On the basis of materials thus obtained vaccine "Hep-A-in-Vac" was recommended for use in medical practice for the prophylaxis of hepatitis A among adults.
